Lentiviral Vpx Accessory Factor Targets VprBP/DCAF1 Substrate Adaptor for Cullin 4 E3 Ubiquitin Ligase to Enable Macrophage Infection
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Vpx is a small virion-associated adaptor protein encoded by viruses of the HIV-2/SIVsm lineage of primate lentiviruses that enables these viruses to transduce monocyte-derived cells. This probably reflects the ability of Vpx to overcome an as yet uncharacterized block to an early event in the virus life cycle in these cells, but the underlying mechanism has remained elusive. Using biochemical and proteomic approaches, we have found that Vpx protein of the pathogenic SIVmac 239 strain associates with a ternary protein complex comprising DDB1 and VprBP subunits of Cullin 4-based E3 ubiquitin ligase, and DDA1, which has been implicated in the regulation of E3 catalytic activity, and that Vpx participates in the Cullin 4 E3 complex comprising VprBP. We further demonstrate that the ability of SIVmac as well as HIV-2 Vpx to interact with VprBP and its associated Cullin 4 complex is required for efficient reverse transcription of SIVmac RNA genome in primary macrophages. Strikingly, macrophages in which VprBP levels are depleted by RNA interference resist SIVmac infection. Thus, our observations reveal that Vpx interacts with both catalytic and regulatory components of the ubiquitin proteasome system and demonstrate that these interactions are critical for Vpx ability to enable efficient SIVmac replication in primary macrophages. Furthermore, they identify VprBP/DCAF1 substrate receptor for Cullin 4 E3 ubiquitin ligase and its associated protein complex as immediate downstream effector of Vpx for this function. Together, our findings suggest a model in which Vpx usurps VprBP-associated Cullin 4 ubiquitin ligase to enable efficient reverse transcription and thereby overcome a block to lentivirus replication in monocyte-derived cells, and thus provide novel insights into the underlying molecular mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was previously reported that in myeloid cells transduced with HIV-2, Vpx prevents the inhibition of HIV-1 infection by associating with and hijacking a cellular E3 ubiquitin-protein ligase complex, including the proteins cullin 4 and DCAF1 [82,83].”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 1×
“To obtain further insight into the role of VprBP, we knocked down its expression in macrophages by RNA interference (RNAi, [25]).”
BackgroundEng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“Tandem mass (MS/MS) spectra were interpreted using SEQUEST [37] against a database of 82242 sequences, consisting of hfa-tagged SIVmac Vpx, usual contaminants, and 40873 human proteins, as well as, to estimate false discovery rates, randomized amino acid sequences derived from each non-redundant protein entry.”
MethodFunction and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148 · cited 2×
“substrate adaptor for Cullin 4-based E3 ubiquitin ligases ([15] reviewed in [16,17]).”
BackgroundTabb, D. L., McDonald, W. H., & Yates, J. R. (2002) · Journal of Proteome Research · doi:10.1021/pr015504q · Cited by 1,367 · cited 1×
“Peptide hits from multiple runs were compared using CONTRAST [38].”
MethodGroisman, R., Polanowska, J., Kuraoka, I., Sawada, J.-I., Saijo, M., Drapkin, R., Kisselev, A. F., Tanaka, K., & Nakatani, Y. (2003) · Cell · doi:10.1016/s0092-8674(03)00316-7 · Cited by 744 · cited 1×
“[23]).”
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., & Sodroski, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509996103 · Cited by 739 · cited 1×
“The phenotype of Vpx-deficient virions is reminiscent of that resulting from a block to retrovirus replication imposed by tripartite motif protein 5α (TRIM5α) restriction factors. TRIM5α is a E3 ubiquitin ligase that inactivates the incoming virions, probably by deregulating their uncoating so rapidly that the late re…”
BackgroundJin, J., Arias, E. E., Chen, J., Harper, J. W., & Walter, J. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.010 · Cited by 632 · cited 1×
“). Cullin 4 is a scaffold protein that assembles a family of E3 ubiquitin ligase complexes. DDB1 is an obligatory subunit of all Cullin 4 E3's that bridges the catalytic cores organized on the Cullin 4 scaffold to a substrate-recruiting subunit, and VprBP/DCAF1 is a putative substrate adaptor for Cullin 4-based E3 ubi…”
BackgroundDCAFs, the Missing Link of the CUL4-DDB1 Ubiquitin Ligase
Lee, J., & Zhou, P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.001 · Cited by 460 · cited 1×
“substrate adaptor for Cullin 4-based E3 ubiquitin ligases ([15] reviewed in [16,17]).”
BackgroundPaxton, W., Connor, R. I., & Landau, N. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7229-7237.1993 · Cited by 371 · cited 1×
“Furthermore, the incoming virions probably contain at most only several hundred Vpx molecules, similar to Vpr, which also is virion recruited through its interaction with Gag p6 [6,30,31].”
BackgroundLe Rouzic, E., Belaïdouni, N., Estrabaud, E., Morel, M., Rain, J.-C., Transy, C., & Margottin-Goguet, F. (2007) · Cell Cycle · doi:10.4161/cc.6.2.3732 · Cited by 267
Cited by
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Self-citationHIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase
Goldstone, D. C., Ennis-Adeniran, V., Hedden, J. J., Groom, H. C. T., Rice, G. I., Christodoulou, E., Walker, P. A., Kelly, G., Haire, L. F., Yap, M. W., et al. (2011) · Nature · doi:10.1038/nature10623 · Cited by 831
SAMHD1 restricts HIV-1 infection in resting CD4+ T cells
Baldauf, H.-M., Pan, X., Erikson, E., Schmidt, S., Daddacha, W., Burggraf, M., Schenkova, K., Ambiel, I., Wabnitz, G., Gramberg, T., et al. (2012) · Nature Medicine · doi:10.1038/nm.2964 · Cited by 597
HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
Malim, M. H., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.04.008 · Cited by 551
“Rather than increasing the activity of the cullin4A-DDB1DCAF1 complex toward normal substrates, an alternative model is that Vpr recruits a novel substrate (whose expression is necessary for cell-cycle progression) for ubiquitylation (and degradation).”
BackgroundInfluentialImmune Evasion and Counteraction of Restriction Factors by HIV-1 and Other Primate Lentiviruses
Kirchhoff, F. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.004 · Cited by 315
White, T. E., Brandariz-Nuñez, A., Valle-Casuso, J. C., Amie, S., Nguyen, L. A., Kim, B., Tuzova, M., & Diaz-Griffero, F. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.03.005 · Cited by 303
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Goujon C, Rivière L, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix JL, Cimarelli A. SIVSM/ HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells.”
BackgroundInfluentialIntrinsic host restrictions to HIV-1 and mechanisms of viral escape
Simon, V., Bloch, N., & Landau, N. R. (2015) · Nature Immunology · doi:10.1038/ni.3156 · Cited by 260
Berger, A., Sommer, A. F. R., Zwarg, J., Hamdorf, M., Welzel, K., Esly, N., Panitz, S., Reuter, A., Ramos, I., Jatiani, A., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002425 · Cited by 243
“In addition to confirmed Vpx interacting proteins such as VprBP [30] and DDB1 [17] we isolated a 72 kDa protein, which was determined to be SAM domain and HD domain containing protein 1 (SAMHD1).”
BackgroundAPOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells
Berger, G., Durand, S., Fargier, G., Nguyen, X.-N., Cordeil, S., Bouaziz, S., Muriaux, D., Darlix, J.-L., & Cimarelli, A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002221 · Cited by 207
“almost all SIV and HIV-2 strains tested [56,67,69,73–78],”
BackgroundAhn, J., Hao, C., Yan, J., DeLucia, M., Mehrens, J., Wang, C., Gronenborn, A. M., & Skowronski, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340711 · Cited by 184
“In particular, Vpx tightly associates with DDB1- and the CUL4-associated factor 1 (DCAF1) substrate receptor subunit of the CRL4 E3 ubiquitin ligase complex, and this interaction is linked to Vpx ability to relieve the inhibition of HIV/SIV infection of myeloid cells (11, 13, 22).”
BackgroundResultInfluentialSt Gelais, C., de Silva, S., Amie, S. M., Coleman, C. M., Hoy, H., Hollenbaugh, J. A., Kim, B., & Wu, L. (2012) · Retrovirology · doi:10.1186/1742-4690-9-105 · Cited by 191
“Treatment of DCs, monocytes, macrophages, and differentiated monocytic cell lines with Vpx-containing SIV virus-like particles (VLPs) has been shown to enhance HIV-1 infection in these cells [11-13,16,24-30].”
BackgroundRole of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac
Brandariz-Núñez, A., Valle‐Casuso, J. C., White, T. E., Laguette, N., Benkirane, M., Brojatsch, J., & Diaz‐Griffero, F. (2012) · Retrovirology · doi:10.1186/1742-4690-9-49 · Cited by 160
“The nuclear localized SAMHD1 blocks retroviral infection before reverse transcription [10-14].”
BackgroundKogan, M., & Rappaport, J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-25 · Cited by 203
“Recently, it was shown that SIV/HIV-2 Vpx overcomes a block to reverse transcription in macrophages, further suggesting that HIV-1 Vpr may increase viral permissiveness in myeloid cells as well [137-139].”
BackgroundHIV accessory proteins versus host restriction factors
Strebel, K. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.08.004 · Cited by 132
Restriction of diverse retroviruses by SAMHD1
Gramberg, T., Kahle, T., Bloch, N., Wittmann, S., Müllers, E., Daddacha, W., Hofmann, H., Kim, B., Lindemann, D., & Landau, N. R. (2013) · Retrovirology · doi:10.1186/1742-4690-10-26 · Cited by 137
“Upon release from the virion, Vpx is thought to form a complex with the CRL4A E3 ubiquitin ligase [11-13] that induces the ubiquitination and proteasomal degradation of SAMHD1.”
Goujon, C., Arfi, V., Pertel, T., Luban, J., Lienard, J., Rigal, D., Darlix, J.-L., & Cimarelli, A. (2008) · Journal of Virology · doi:10.1128/jvi.01181-08 · Cited by 142
“ences (38, 40), reflecting a subtle and dynamic interplay be-”
BackgroundResultInfluentialYurkovetskiy, L., Guney, M. H., Kim, K., Goh, S. L., McCauley, S., Dauphin, A., Diehl, W. E., & Luban, J. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0256-x · Cited by 143
Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1
White, T. E., Brandariz-Núñez, A., Valle‐Casuso, J. C., Amie, S. M., Nguyen, L. A., Kim, B., Brojatsch, J., & Diaz‐Griffero, F. (2012) · Virology · doi:10.1016/j.virol.2012.10.029 · Cited by 150
Structural basis of lentiviral subversion of a cellular protein degradation pathway
Schwefel, D., Groom, H. C. T., Boucherit, V. C., Christodoulou, E., Walker, P. A., Stoye, J. P., Bishop, K. N., & Taylor, I. A. (2014) · Nature · doi:10.1038/nature12815 · Cited by 127
Sunseri, N., O'Brien, M., Bhardwaj, N., & Landau, N. R. (2011) · Journal of Virology · doi:10.1128/jvi.00346-11 · Cited by 123
Bergamaschi, A., Ayinde, D., David, A., Le Rouzic, E., Morel, M., Collin, G., Descamps, D., Damond, F., Brun-Vezinet, F., Nisole, S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00187-09 · Cited by 121
“First, it is conserved across several primate species based on our finding that Vpx from SIVsm can substitute for HIV-2 Vpx and on the reciprocal observations that HIV-2 Vpx can complement Vpx-defective SIVmac (43).”
InfluentialLum, K. K., & Cristea, I. M. (2016) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1147353 · Cited by 113
“It was previously reported that in myeloid cells transduced with HIV-2, Vpx prevents the inhibition of HIV-1 infection by associating with and hijacking a cellular E3 ubiquitin-protein ligase complex, including the proteins cullin 4 and DCAF1 [82,83].”
BackgroundDistinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B
Hannah, J., & Zhou, P. (2015) · Gene · doi:10.1016/j.gene.2015.08.064 · Cited by 110
“Evidently, the interaction between Vpx and CRL4DCAF1 is the basis for HIV-2's and SIV's ability to efficiently infect human myeloid cells (Srivastava et al., 2008).”
BackgroundHost hindrance to HIV-1 replication in monocytes and macrophages
Bergamaschi, A., & Pancino, G. (2010) · Retrovirology · doi:10.1186/1742-4690-7-31 · Cited by 104
“In the same vein, recent studies concerning HIV-1 and HIV-2 infection of Mφ led to the conclusion that nuclear entry may not be the limiting step for HIV-1 infection, but that the restrictions affect earlier steps before or during reverse transcription [27,134-137].”
ResultThe Inside Out of Lentiviral Vectors
Durand, S., & Cimarelli, A. (2011) · Viruses · doi:10.3390/v3020132 · Cited by 98
“Vpx is a nonstructural viral protein that is incorporated into viral particles and is thus present during the early phases of infection, where it exerts a positive effect on the process of reverse transcription [133–137].”
BackgroundAllouch, A., David, A., Amie, S. M., Lahouassa, H., Chartier, L., Margottin-Goguet, F., Barré‐Sinoussi, F., Kim, B., Sáez‐Cirión, A., & Pancino, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306719110 · Cited by 106
Host restriction factors in retroviral infection: promises in virus-host interaction
Zheng, Y., Jeang, K.-T., & Tokunaga, K. (2012) · Retrovirology · doi:10.1186/1742-4690-9-112 · Cited by 120
“Vpx also interacts with DCAF1, but this interaction is required for Vpx promotion of viral replication [309,312].”
BackgroundInfluentialBerger, G., Durand, S., Goujon, C., Nguyen, X.-N., Cordeil, S., Darlix, J., & Cimarelli, A. (2011) · Nature Protocols · doi:10.1038/nprot.2011.327 · Cited by 108
“A number of reasons have been put forward to explain the relative resistance of MDDCs to lentiviral infection; among them, we and others have proposed that they specifically express a cellular factor that hampers the early phases of infection, a so-called restriction facto”
BackgroundRNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load
Poltronieri, P., Sun, B., & Mallardo, M. (2015) · Current Genomics · doi:10.2174/1389202916666150707160613 · Cited by 102
“Vpx is a small virion-associated adaptor protein encoded by viruses of the HIV-2/SIVsm lineage of primate lentiviruses, a Vpr paralogue, that enables these viruses to infect monocytederived cells.”
BackgroundInfluentialThe DDB1–DCAF1–Vpr–UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction
Wu, Y., Zhou, X., Barnes, C. O., DeLucia, M., Cohen, A. E., Gronenborn, A. M., Ahn, J., & Calero, G. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3284 · Cited by 97
Kaushik, R., Zhu, X., Stranska, R., Wu, Y., & Stevenson, M. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.022 · Cited by 95
“…time to recover after it has been neutralized by Vpx. Previous demonstrations that the biological activity of Vpx required association with damaged DNA binding protein 1 (DDB1) (Sharova et al., 2008, Srivastava et al., 2008) has parallels with viral proteins that circumvent the interferon response.”
BackgroundFregoso, O. I., Ahn, J., Wang, C., Mehrens, J., Skowronski, J., & Emerman, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003496 · Cited by 95
“The CRL4 E3 complex usurped by Vpx consists of DCAF1, DDB1, CUL4 and RBX1 [8–12].”
BackgroundSAMHD1: At the Crossroads of Cell Proliferation, Immune Responses, and Virus Restriction
Ballana, E., & Esté, J. A. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.08.002 · Cited by 102
Limelight on two HIV/SIV accessory proteins in macrophage infection: Is Vpx overshadowing Vpr?
Ayinde, D., Maudet, C., Transy, C., & Margottin-Goguet, F. (2010) · Retrovirology · doi:10.1186/1742-4690-7-35 · Cited by 87
“The ability of HIV-1 to transduce macrophages, and to a lesser extent dendritic cells, in the absence of any accessory proteins may suggest that the cellular restriction factor antagonized by Vpx senses a viral component that is highly specific for HIV-2/SIVsm and which is not present in HIV-1.”
InfluentialAmbrose, Z., Lee, K., Ndjomou, J., Xu, H., Oztop, I., Matous, J., Takemura, T., Unutmaz, D., Engelman, A., Hughes, S. H., et al. (2012) · Journal of Virology · doi:10.1128/jvi.05887-11 · Cited by 92
“Vpx has recently been shown to degrade the restriction factor SAMHD1 (11, 14).”
BackgroundInfluentialHepatitis B Virus HBx Protein Interactions with the Ubiquitin Proteasome System
Minor, M., & Slagle, B. L. (2014) · Viruses · doi:10.3390/v6114683 · Cited by 95
“Virus family Virus (protein) 1 Cellular pathway altered Reference Paramyxoviridae Simian Virus 5 (V) Innate immunity [97] HPIV2 (V) Innate immunity [96] Mumps (V) Innate immunity [104] Hepadnaviridae HBV (HBx) Unknown Retroviridae HIV-1 (Vpr) Cell cycle [105,106] HIV-2 (Vpx) Cell cycle [107] Flaviviridae HCV (NS3/4A)…”
BackgroundCyclinA2-Cyclin-dependent Kinase Regulates SAMHD1 Protein Phosphohydrolase Domain
Yan, J., Hao, C., DeLucia, M., Swanson, S. K., Florens, L. A., Washburn, M. P., Ahn, J., & Skowroński, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646588 · Cited by 94
“MudPIT analyses of purified protein complexes were performed as described previously (34, 35).”
MethodSelf-citationCUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases
Sharma, P., & Nag, A. (2014) · Open Biology · doi:10.1098/rsob.130217 · Cited by 99
Hiding in Plain Sight: How HIV Evades Innate Immune Responses
Manel, N., & Littman, D. R. (2011) · Cell · doi:10.1016/j.cell.2011.09.010 · Cited by 76
Self-citationHIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins
Hrecka, K., Hao, C., Shun, M.-C., Kaur, S., Swanson, S. K., Florens, L., Washburn, M. P., & Skowronski, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605023113 · Cited by 80
“Transfections of HEK 293T cells and immunoprecipitations were performed as described previously (34, 63).”
MethodSelf-citationInnate Immune Sensing of HIV-1 by Dendritic Cells
Luban, J. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.002 · Cited by 87
“Vpx was then shown to associate with the CUL4A E3 ubiquitin ligase complex via direct binding to DCAF1 (Sharova et al., 2008; 2008; Srivastava et al., 2008; 2008; Bergamaschi et al., 2009; 2009) and heterokaryon experiments demonstrated the presence of a dominant-acting inhibitor in myeloid cells that was sensitive to…”
BackgroundInfluentialHIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137
Zhang, F., & Bieniasz, P. D. (2020) · eLife · doi:10.7554/elife.55806 · Cited by 75
“CRL4 recruitment by virion-associated Vpx and some SIV Vpr proteins can induce the degradation of the antiviral protein SAMHD1 following viral entry (14–16), but HIV-1, HIV-2, and many SIV Vpr proteins do not exhibit this activity.”
BackgroundInfluentialPertel, T., Reinhard, C., & Luban, J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-49 · Cited by 74
“Vpx associates with the DDB1/RBX1/CUL4A E3 ubiquitin ligase complex via interaction with DCAF1 [12,13,15].”
BackgroundInfluentialRestricting HIV the SAMHD1 way: through nucleotide starvation
Ayinde, D., Casartelli, N., & Schwartz, O. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2862 · Cited by 86
Evidence for an Activation Domain at the Amino Terminus of Simian Immunodeficiency Virus Vpx
Gramberg, T., Sunseri, N., & Landau, N. R. (2010) · Journal of Virology · doi:10.1128/jvi.01437-09 · Cited by 69
“Consistent with previous reports (16, 32, 35), Vpx showed a pronounced phenotype in MDM (Fig.”
BackgroundResultInfluentialSIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release
Zhang, F., Landford, W. N., Ng, M., McNatt, M. W., Bieniasz, P. D., & Hatziioannou, T. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002039 · Cited by 70
“There is also emerging evidence suggesting that Vpx might also antagonize yet unidentified host restriction factors [2–4].”
Wei, W., Guo, H., Han, X., Liu, X., Zhou, X., Zhang, W., & Yu, X.-F. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01835.x · Cited by 73
“Consistent with this concept, Vpxdeficient viruses exhibit defects in the accumulation of viral DNA during reverse transcription soon after the infection of myeloid cells (Fujita et al., 2008; Sharova et al., 2008; Srivastava et al., 2008; Gramberg et al., 2010).”
BackgroundMethodInfluentialKlockow, L. C., Sharifi, H. J., Wen, X., Flagg, M., Furuya, A. K. M., Nekorchuk, M. D., & de Noronha, C. M. C. (2013) · Virology · doi:10.1016/j.virol.2013.06.010 · Cited by 71
“Vpx enhances macrophage infection albeit more dramatically than HIV-1 Vpr (Sharova et al., 2008; Srivastava et al., 2008) by combating antiviral protein SAMHD1 through the CRL4DCAF1 complex.”
Rasheedi, S., Shun, M.-C., Serrao, E., Sowd, G. A., Qian, J., Hao, C., Dasgupta, T., Engelman, A. N., & Skowronski, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721647 · Cited by 65
“Protein complexes were immunoprecipitated via FLAG or HA epitope tag (38, 41).”
MethodLentivirus Vpr and Vpx accessory proteins usurp the cullin4–DDB1 (DCAF1) E3 ubiquitin ligase
Romani, B., & Cohen, É. A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.09.010 · Cited by 63
“Studies in myeloid cells designed to determine which step of the virus life cycle is affected by Vpx, revealed that the viral protein targeted the process of reverse transcription [13,14 ,44,45].”
BackgroundInfluentialBaldauf, H., Stegmann, L., Schwarz, S.-M., Ambiel, I., Trotard, M., Martin, M., Burggraf, M., Lenzi, G. M., Lejk, H., Pan, X., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613635114 · Cited by 72
Su, J., Rui, Y., Lou, M., Yin, L., Xiong, H., Zhou, Z., Shen, S., Chen, T., Zhang, Z., Zhao, N., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0585-4 · Cited by 65
Belzile, J.-P., Abrahamyan, L. G., Gérard, F. C. A., Rougeau, N., & Cohen, É. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001080 · Cited by 57
“This association is required for the inactivation of the restriction factor and probably leads to its proteasomal degradation [27,28,29].”
BackgroundSchwefel, D., Boucherit, V., Christodoulou, E., Walker, P. A., Stoye, J. P., Bishop, K. N., & Taylor, I. A. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.004 · Cited by 60
“Vpr and Vpx from HIV and SIVs target the cullin-4 ligase substrate receptor DDB1- and CUL4-associated factor 1 (DCAF1, also known as VprBP) from their host (Bergamaschi et al., 2009; Hrecka et al., 2007; Le Rouzic et al., 2007; Srivastava et al., 2008).”
Bloch, N., O’Brien, M. P., Norton, T. D., Polsky, S. B., Bhardwaj, N., & Landau, N. R. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0119 · Cited by 61
“Upon entry into the cell, Vpx is thought to transit to the nucleus where it associates with SAMHD1 and recruits a CRL4 E3 ubiquitin ligase complex consisting of DNA damage binding protein 1 (DDB1), Cullin 4-A CUL4A, and DDB1 and Cullin-associated factor 1.(31,32) The complex then mediates the proteasomal degradation o…”
Cyclin L2 Is a Critical HIV Dependency Factor in Macrophages that Controls SAMHD1 Abundance
Kyei, G. B., Cheng, X., Ramani, R., & Ratner, L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.009 · Cited by 56
“HIV-2 and its counterpart, simian immunodeficiency virus (SIV), encode the accessory protein Vpx, which facilitates the efficient infection of quiescent noncycling cells like macrophages, resting T cells, and dendritic cells (Ueno et al., 2003; Srivastava et al., 2008).”
SAMHD1 Host Restriction Factor: A Link with Innate Immune Sensing of Retrovirus Infection
Sze, A., Olagnier, D. P., Lin, R., van Grevenynghe, J., & Hiscott, J. B. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.022 · Cited by 60
“Conversely, HIV-2 or SIV that is Vpx deficient is unable to productively infect these cells [68–71].”
BackgroundMlčochová, P., Caswell, S. J., Taylor, I. A., Towers, G. J., & Gupta, R. K. (2017) · The EMBO Journal · doi:10.15252/embj.201796880 · Cited by 59
“The Vpx Q76A variant that is able to interact with SAMHD1, but not DCAF1, fails to cause SAMHD1 degradation (Srivastava et al, 2008; Hrecka et al, 2011) and fails to increase dNTP levels in dendritic cells (Reinhard et al, 2014).”
BackgroundSAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity
Mauney, C. H., & Hollis, T. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1454912 · Cited by 64
“The loss of SAMHD1 and subsequent increase in dNTPs is sufficient to permit productive viral infection for Vpx containing virions.”
BackgroundInfluentialBelzile, J.-P., Richard, J., Rougeau, N., Xiao, Y., & Cohen, E. A. (2010) · Journal of Virology · doi:10.1128/jvi.02590-09 · Cited by 49
“TAP-Vpr(1-78), TAP-Vpr (1-86), and TAP-Vpr(R87A,R88A) were generated”
BackgroundMethodInfluentialSchaller, T., Pollpeter, D., Apolonia, L., Goujon, C., & Malim, M. H. (2014) · Retrovirology · doi:10.1186/1742-4690-11-29 · Cited by 49
“complex through interaction with DCAF1, leading to ubiquitination and proteasomal degradation of its binding partners [32-34].”
BackgroundUnmasking immune sensing of retroviruses: Interplay between innate sensors and host effectors
van Montfoort, N., Olagnier, D. P., & Hiscott, J. B. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.08.006 · Cited by 54
Imaging HIV-1 Genomic DNA from Entry through Productive Infection
Stultz, R. D., Cenker, J. J., & McDonald, D. (2017) · Journal of Virology · doi:10.1128/jvi.00034-17 · Cited by 45
“Proviral clones containing either inactive vpx or vpx and vpr open reading frames were introduced into pSIV3 to produce pSIV3 Vpr and pSIV3 Vpx Vpr as previously described (33, 56) and were kindly provided by Jacek Skowronski.”
MethodHIV relies on neddylation for ubiquitin ligase-mediated functions
Nekorchuk, M. D., Sharifi, H. J., Furuya, A. K. M., Jellinger, R. M., & de Noronha, C. M. C. (2013) · Retrovirology · doi:10.1186/1742-4690-10-138 · Cited by 47
“Vpx from HIV-2 and SIV boosts infection of primary myeloid-derived cells [18-21], and has been shown to act through the CRL4 complex in this capacity [18-20].”
BackgroundInhibition of CUL4A Neddylation Causes a Reversible Block to SAMHD1-Mediated Restriction of HIV-1
Hofmann, H., Norton, T. D., Schultz, M. L., Polsky, S. B., Sunseri, N., & Landau, N. R. (2013) · Journal of Virology · doi:10.1128/jvi.02002-13 · Cited by 46
“Vpx associates with the substrate receptor DCAF1 and with SAMHD1 at its carboxy terminus (14, 18).”
BackgroundVpr and Its Interactions with Cellular Proteins
Planelles, V., & Bénichou, S. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-02175-6_9 · Cited by 51
Reinhard, C., Bottinelli, D., Kim, B., & Luban, J. (2014) · Retrovirology · doi:10.1186/1742-4690-11-12 · Cited by 50
“Via direct interaction with DCAF1, Vpx acts as an adaptor that brings SAMHD1 to the CUL4A E3 ubiquitin ligase complex [32,33].”
BackgroundThe HIV1 Protein Vpr Acts to Enhance Constitutive DCAF1-Dependent UNG2 Turnover
Wen, X., Casey Klockow, L., Nekorchuk, M., Sharifi, H. J., & de Noronha, C. M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030939 · Cited by 41
“The same ubiquitin ligase complex is also recruited by the closely related HIV2- and SIVSM Vpx proteins to defeat an antiviral factor that blocks efficient reverse transcription in cells of the monocytic lineage [8,9,10,11].”
BackgroundYan, J., Shun, M.-C., Hao, C., Zhang, Y., Qian, J., Hrecka, K., DeLucia, M., Monnie, C. M., Ahn, J., & Skowroński, J. (2018) · mBio · doi:10.1128/mbio.01732-18 · Cited by 51
Increasing intracellular dNTP levels improves prime editing efficiency
Liu, P., Ponnienselvan, K., Nyalile, T., Oikemus, S., Joynt, A. T., Iyer, S., Kelly, K. L., Guo, D., Kyawe, P. P., Vanderleeden, E., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02405-x · Cited by 46
“Human immunodeficiency virus 2 (HIV-2) packages an accessory protein (VPX; encoded by the gene HIV2gp3 ) within the virion that targets SAMHD1 for degradation via the cullin 4-based E3 ubiquitin ligase pathway 34,35 .”
HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells
Yan, J., Shun, M.-C., Zhang, Y., Hao, C., & Skowroński, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818401116 · Cited by 52
“Virus particles were produced, concentrated, and normalized by quantitative Gag immunoblotting, as previously described (75, 76).”
MethodMinor, M., Hollinger, F. B., McNees, A. L., Jung, S. Y., Jain, A., Hyser, J. M., Bissig, K., & Slagle, B. L. (2020) · Cells · doi:10.3390/cells9040834 · Cited by 46
“Retroviridae HIV‐1e (Vpr) Cell cycle [42,50,51] HIV‐2f (Vpx) Cell cycle [52]”
BackgroundMultifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions
Fujita, M., Otsuka, M., Nomaguchi, M., & Adachi, A. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.636 · Cited by 42
“Our results are consistent with those independently obtained by others [10].”
BackgroundResultInfluentialdNTP pool modulation dynamics by SAMHD1 protein in monocyte-derived macrophages
Hollenbaugh, J. A., Tao, S., Lenzi, G. M., Ryu, S., Kim, D., Diaz‐Griffero, F., Schinazi, R. F., & Kim, B. (2014) · Retrovirology · doi:10.1186/preaccept-5624405321277583 · Cited by 41
Vpx is Critical for SIVmne infection of pigtail macaques
Belshan, M., Kimata, J. T., Brown, C. R., Cheng, X., McCulley, A., Larsen, A., Thippeshappa, R., Hodara, V. L., Giavedoni, L. D., Hirsch, V. M., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-32 · Cited by 45
“DCAF1, we analyzed the SIV Vpx mutants for their ability to bind DCAF1 (Figure 7) [18-21].”
BackgroundResultInfluentialContribution of oligomerization to the anti-HIV-1 properties of SAMHD1
Brandariz-Núñez, A., Valle‐Casuso, J. C., White, T. E., Nguyen, L. A., Bhattacharya, A., Wang, Z., Demeler, B., Amie, S. M., Knowlton, C., Kim, B., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-131 · Cited by 41
“HeLa cells were cotransfected with plasmids allowing expression of SAMHD1-FLAG variants and the Vpx protein of HIV-2ROD (VpxROD) or the Vpx protein of SIVrcm (Vpxrcm), as described [44].”
BackgroundInfluentialBerger, A., Münk, C., Schweizer, M., Cichutek, K., Schüle, S., & Flory, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090977 · Cited by 44
The functions of the HIV1 protein Vpr and its action through the DCAF1·DDB1·Cullin4 ubiquitin ligase
Casey, L., Wen, X., & de Noronha, C. M. C. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.018 · Cited by 44
“The restriction occurs during reverse transcription; real-time PCR of viral DNA at different stages early during infection showed that early, late, and post-nuclear imported transcripts are decreased in macrophages infected with HIV-2/SIV vpx(−) virus [39,42,43,117].”
BackgroundInfluentialDragin, L., Nguyen, L. A., Lahouassa, H., Sourisce, A., Kim, B., Ramírez, B. C., & Margottin-Goguet, F. (2013) · Retrovirology · doi:10.1186/1742-4690-10-30 · Cited by 39
“These last years, Vpx was recognized as a viral protein that counteracts the cellular environment during the early phases of infection [43-48] until its cellular target was identified as being SAMHD1 [26,28].”
BackgroundYang, S., Zhan, Y., Zhou, Y., Jiang, Y., Zheng, X., Yu, L., Tong, W., Gao, F., Li, L., Huang, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep29665 · Cited by 43
“HIV-2 and certain strains of SIVsm that encode the Vpx protein utilized the CRL4 DCAF1 and E3 ubiquitin ligase complex to recruit SAMHD1 for proteasome-dependent degradation 10–12 .”
Humbert, J.-M., Frecha, C. A., Amirache, F., N′Guyen, T. H., Boni, S., Cosset, F., Verhoeyen, E., & Halary, F. A. (2012) · Journal of Virology · doi:10.1128/jvi.06283-11 · Cited by 38
“In accordance with previous results (33, 51, 78), we confirmed that Vpx allowed for macrophage and monocyte transduction by H/FLVs (data not shown).”
ResultSIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors
Berger, G., Goujon, C., Darlix, J. L., & Cimarelli, A. (2008) · Gene Therapy · doi:10.1038/gt.2008.128 · Cited by 39
SAMHD1-Dependent and -Independent Functions of HIV-2/SIV Vpx Protein
Fujita, M., Nomaguchi, M., Adachi, A., & Otsuka, M. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00297 · Cited by 37
“Thus, in the presence of SAMHD1, the concentration of dNTPs becomes low and reverse transcription is inhibited. and F80 interacts with DCAF1, a subunit of the Cullin4-based E3 ubiquitin ligase complex (Srivastava et al., 2008).”
BackgroundInfluentialBoasso, A. (2013) · Scientifica · doi:10.1155/2013/580968 · Cited by 46
“Thus, SAMHD1 ubiquitylation is mediated by the cullin-4A ubiquitin ligase (CUL4A)-DNA damage-binding protein 1 (DDB1) complex (CUL4A-DDB1), which is assembled by Vpx via recruitment of the DDB1 CUL4A associated factor 1 (DCAF1) [270–273].”
BackgroundFunctional Analysis of the Relationship between Vpx and the Restriction Factor SAMHD1
Berger, G., Turpin, J., Cordeil, S., Tartour, K., Nguyen, X.-N., Mahieux, R., & Cimarelli, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.403816 · Cited by 35
“Thus, although the stability of Vpx seems to be influenced by Vpx:Vpx interactions, neither parameters are limiting in the functionality of Vpx, suggesting that Vpx may remove SAMHD1as amonomer and in anhighly efficientmanner, through the Cul4A-DDB1-DCAF1 E3 ubiquitin ligase complex, (3, 4, 33, 34), although a DCAF1-i…”
BackgroundWei, W., Guo, H., Liu, X., Zhang, H., Qian, L., Luo, K., Markham, R. B., & Yu, X. (2013) · Journal of Virology · doi:10.1128/jvi.02568-13 · Cited by 39
“Vpr but not Vpx has been observed to enhance the neddylation of Cullin4A (13, 18, 22).”
BackgroundInfluentialHUSH, a Link Between Intrinsic Immunity and HIV Latency
Chougui, G., & Margottin-Goguet, F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00224 · Cited by 40
“The same positive impact of Vpx was further observed on HIV-2/SIVsmm and HIV-1 full length viruses and was shown to depend on the proteasome, precisely on the hijacking of the Cul4A-DDB1DCAF1 ubiquitin ligase (Goujon et al., 2007; Fujita et al., 2008a; Sharova et al., 2008; Srivastava et al., 2008; Bergamaschi et al.,…”
BackgroundInfluentialHIV-derived vectors for therapy and vaccination against HIV
Nunzio, F. D., Félix, T., Arhel, N. J., Nisole, S., Charneau, P., & Beignon, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.089 · Cited by 38
The Dynamic Interplay between HIV-1, SAMHD1, and the Innate Antiviral Response
Antonucci, J. M., Gelais, C. S., & Wu, L. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01541 · Cited by 36
“HIV-1 infection can be enhanced in these cells by Vpx, an accessory protein encoded by HIV-2 and certain lineages of simian immunodeficiency viruses (SIVs) (50, 51).”
BackgroundInfluentialSAMHD1 … and Viral Ways around It
Deutschmann, J., & Gramberg, T. (2021) · Viruses · doi:10.3390/v13030395 · Cited by 34
Antiretroviral restriction factors
Hatziioannou, T., & Bieniasz, P. D. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.007 · Cited by 33
“Sharova N, Wu Y, Zhu X, Stranska R, Kaushik R, Sharkey M, Stevenson M: Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction.”
DeLucia, M., Mehrens, J., Wu, Y. G., & Ahn, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.469007 · Cited by 32
Guo, H., Wei, W., Wei, Z., Liu, X., Evans, S. L., Yang, W., Wang, H., Guo, Y., Zhao, K., Zhou, J.-Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066201 · Cited by 31
New insights into an X-traordinary viral protein
Schaller, T., Bauby, H., Hué, S., Malim, M. H., & Goujon, C. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00126 · Cited by 33
“RNAi-mediated depletion of DCAF1 or DDB1 profoundly reduced SIVmac as well as HIV-2 infection of macrophages (Sharova et al., 2008; Srivastava et al., 2008; Bergamaschi et al., 2009).”
BackgroundMethodInfluentialHepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection
Morikawa, K., Shimazaki, T., Takeda, R., Izumi, T., Umumura, M., & Sakamoto, N. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.08.54 · Cited by 34
“In addition to HBV, simian virus 5 (42), human parainfluenza virus 2 (43), mumps virus, HIV-I (44,45), HIV-II (46), murine gammaherpesvirus 68 (47), and Epstein-Barr virus (48) have all been observed to target the ubiquitin ligase activity of the CUL4-DDB1 E3 ligase, in order to counteract the host innate immune respo…”
BackgroundCellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses
Becker, T., Le‐Trilling, V. T. K., & Trilling, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071636 · Cited by 31
“Well-known examples of viral exploitation of DDB1 and/or CRLs include the hepatitis B virus (HBV) protein HBx [84, [89] [90] [91] [92] , the HIV-1-and HIV-2-encoded protein Vpr [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] , HIV-2 Vpx [103] [104] [105] [106] [107] [108] [109] , parainfluenza virus (PIV) V prote…”
Role of the Ubiquitin Proteasome System (UPS) in the HIV-1 Life Cycle
Rojas, V. K., & Park, I.-W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122984 · Cited by 30
“It has been reported that Vpx and Vpr counteract the HUSH complex-mediated inhibition of the virus replication by reducing the steady-state level of these proteins in a DCAF1/CUL4A/B/proteasome-dependent manner [148,149], providing explanations of the impacts of Vpx and Vpr on the reporter gene expression, which is no…”
BackgroundWang, H., Guo, H., Su, J., Rui, Y., Zheng, W., Gao, W., Zhang, W., Li, Z., Liu, G., Markham, R. B., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00225-17 · Cited by 29
“Vpx mutants were cotransfected with pSIVΔEnvΔVpx-GFP (37) and pVSV-G into HEK”
MethodFabits, M., Magalhães, V. G., Chan, B., Girault, V., Elbasani, E., Rossetti, E., Saeland, E., Messerle, M., Pichlmair, A., Lisnić, V. J., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8060790 · Cited by 29
“Because DCAF1 is utilized by multiple viral proteins to modulate the host [22,44,45], we asked whether this complex or the direct UL35 interaction partner DCAF1 itself contributes to the antagonistic function of UL35.”
Metadata
- Authors
- Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Stowers Institute for Medical Research (US)
- New York University (US)
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-05-09
- Volume
- 4
- Issue
- 5
- Pages
- e1000059
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2330158
- OpenAlex
- W2068349374
- Cited by
- 209
- References
- 40
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 7 · 2019: 14 · 2018: 7 · 2017: 10 · 2016: 12 · 2015: 11 · 2014: 24 · 2013: 24 · 2012: 29
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of Allergy and Infectious Diseases (AI-77459, AI 42561, AI033303, R37AI033303, R01AI077459, R01AI042561)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- Vpx, VprBP, DCAF1, DDB1, HIV-2, reverse transcription, ubiquitin-proteasome system, monocyte-derived cells
- MeSH terms
- Animals, Cell Line, Fluoresceins, Humans, Leukocytes, Mononuclear, Macrophages, Simian Immunodeficiency Virus, Signal Transduction, CD4-Positive T-Lymphocytes, Gene Expression Regulation, Viral, Macrophage Colony-Stimulating Factor, Gene Products, vpr, Ubiquitin-Protein Ligases, Cullin Proteins, Adaptor Proteins, Signal Transducing, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.